Atrophy of the prostate gland

From Libre Pathology
Revision as of 01:56, 29 April 2014 by Michael (talk | contribs) (more)
Jump to navigation Jump to search

Atrophy of the prostate gland, also prostatic atrophy, is a common change in the prostate gland.

It usually is seen focally; thus, it is sometimes called partial prostatic atrophy.

On occasion, it can mimic prostate carcinoma, especially atrophic prostate carcinoma.

General

  • Small glands (may mimic Gleason score 3 pattern).
  • Inflammatory atrophy seems to be related to HGPIN and prostate cancer;[1] however, the epidemiology is not compelling that this is a significant (clinical) association.[2]

Microscopic

Features:

  • Glands often have a jagged edges/prows (in cancer the glands tend to have round edges) - key feature.
    • Prow = forward most part of a ship's bow that cuts through the water.[3]
      • You may have come across prow in the context of breast cancer, i.e. tubular carcinoma.
  • Gland density is usually lower than in prostate carcinoma, i.e. glands are not back-to-back - key feature.
  • Atrophic glands are often hyperchromatic.[4]
  • Scant cytoplasm - usually.

Negatives:

  • Nuclei like normal, i.e. nucleoli uncommon.
  • Should have two cell layers, i.e. epithelial and myoepithelial (may be difficult to see).

Notes:

  • Atrophic glands may be scattered with non-atrophic ones.
  • IHC may be misleading - basal cell loss.

DDx:

Atrophy versus cancer

Histologic feature Atrophy Cancer
Glandular architecture/
arrangement
angulated glands, may
look like they originate
from one large duct
round glands,
often back-to-back
Nuclear
hyperchromasia
marked moderate
Cytoplasm scant/minimal moderate, may
be amphophilic
Basal cells may be visible absent
Nucleoli absent present
Secretions in
glands
no yes - eosinophilic
or blue

Sign out

Generally, this finding is not reported; it is considered a normal finding.

See also

References

  1. De Marzo, AM.; Marchi, VL.; Epstein, JI.; Nelson, WG. (Dec 1999). "Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.". Am J Pathol 155 (6): 1985-92. doi:10.1016/S0002-9440(10)65517-4. PMID 10595928.
  2. Celma, A.; Servián, P.; Planas, J.; Placer, J.; Quilez, MT.; Arbós, MA.; de Torres, I.; Morote, J. (Mar 2014). "Clinical Significance of Proliferative Inflammatory Atrophy in Prostate Biopsy.". Actas Urol Esp 38 (2): 122-126. doi:10.1016/j.acuro.2013.04.008. PMID 24129226.
  3. http://en.wikipedia.org/wiki/Prow
  4. SN. June 3, 2009.